Trial Profile
Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2022
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Ventricular dysfunction
- Focus Therapeutic Use
- 08 Mar 2022 Status changed from completed to discontinued.
- 15 Sep 2021 Status changed from active, no longer recruiting to completed.
- 04 Mar 2020 Planned End Date changed from 1 Jun 2019 to 1 Dec 2020.